SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-004039
Filing Date
2017-02-14
Accepted
2017-02-14 18:00:51
Documents
1
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 4221
  Complete submission text file 0000899243-17-004039.txt   5538
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2071 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address
FISHMAN ROBERT S (Reporting) CIK: 0001232237 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-50679 | Film No.: 17611675